Hot spot pollutants: Pharmaceuticals in the environment

Toxicology Letters

Volumn 131, Issue 1-2, 2002, Pages 1-3

  Dietrich, Daniel R ^a   Webb, Simon F ^b   Petry, Thomas ^c  

^a UNIVERSITY OF KONSTANZ   (Germany)

^b PROCTER AND GAMBLE COMPANY   (United States)

^c Weinberg Group   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTILIPEMIC AGENT; DIAZEPAM; DRUG; DRUG METABOLITE; ERYTHROMYCIN; ETHINYLESTRADIOL; METHOTREXATE; SEROTONIN UPTAKE INHIBITOR; STEROID; SURFACE WATER; TETRACYCLINE; THEOPHYLLINE;

AQUATIC ENVIRONMENT; BIODEGRADATION; DRUG ACTIVITY; DRUG DETERMINATION; DRUG METABOLISM; DRUG SOLUBILITY; DRUG USE; ENVIRONMENTAL EXPOSURE; FISH; HUMAN; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; RISK ASSESSMENT; SHORT SURVEY; WASTE WATER MANAGEMENT; WATER CONTAMINATION; WATER POLLUTION;

EID: 0037052894     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-4274(02)00062-0     Document Type: Editorial

References (18)

1. The role of immunoassay in the analysis of microcontaminants in water samples
2. Illicit drugs in municipal sewage: Proposed new non-intrusive tool to heighten public awareness of societal use of illicit/abused drugs and their potential for ecological consequences
3. Pharmaceuticals and personal care products in the environment: Agents of subtle change?
4. Induction of potentiation of parturition in fingernail clams (Sphaerium striatinum) by selective serotonin re-uptake inhibitors (SSRIs)
5. Occurrence, fate and effects of pharmaceutical substances in the environment - A review
6. Determination of clofibric acid and N-(phenylsulfonyl)-sarcosine in sewage river and drinking water
7. Occurrence of antibiotics in the aquatic environment
8. Effects of the synthetic oestrogen 17a-Ethinylestradiol over the life-cycle of the fathead minnow (Pimephales promelas)
9. Pharmaceuticals in the environment - An overview and principle considerations
10. The fate of pharmaceutical chemicals in the environment
11. Environmental risk assessment of human pharmaceuticals in Denmark after normal therapeutic use
12. Nachweis von natürlichen und synthetischen östrogenen in kläranlagen und fliessgewässern
13. Nachweis von arzneimittelrückständen in kläranlagen und flieβgewässern
14. Occurrence of drugs in German sewage treatment plants and rivers
15. Pharmaceuticals and metabolites as contaminants of the aquatic environment
16. Analytical methods for the determination of pharmaceuticals in aqueous environmental samples
17. A data based perspective on the environmental risk assessment of human pharmaceuticals II - Aquatic risk characterization